Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Class A
Common stock
Common Class A
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 27, 2018       97,588,000        
Beginning balance at Dec. 27, 2018 $ 584,309 $ (179)   $ 98 $ 340,462 $ 186 $ 243,563 $ (179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 8,711       8,711      
Exercise of stock options (in shares)       3,741,000        
Exercise of stock options $ 18,798     $ 3 18,795      
Issuance of restricted stock award (in shares)       24,000        
Shares issued under employee stock purchase plan (in shares) 104,363     105,000        
Shares issued under employee stock purchase plan $ 2,445       2,445      
Other comprehensive income gain (loss), net of tax (379)         (379)    
Net income 150,631           150,631  
Ending balance (in shares) at Dec. 26, 2019       101,458,000        
Ending balance at Dec. 26, 2019 764,336     $ 101 370,413 (193) 394,015  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 16,115       16,115      
Exercise of stock options (in shares)       2,485,000        
Exercise of stock options 19,254     $ 2 19,252      
Issuance of restricted stock award (in shares)       369,000        
Issuance of restricted stock awards $ 1     $ 1        
Shares issued under employee stock purchase plan (in shares) 56,389     56,000        
Shares issued under employee stock purchase plan $ 2,344       2,344      
Other comprehensive income gain (loss), net of tax 357         357    
Net income 194,981           194,981  
Ending balance (in shares) at Dec. 31, 2020     104,368,212 104,368,000        
Ending balance at Dec. 31, 2020 997,388     $ 104 408,124 164 588,996  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation expense $ 20,528       20,528      
Exercise of stock options (in shares) 1,252,566     1,253,000        
Exercise of stock options $ 14,736     $ 2 14,734      
Issuance of restricted stock award (in shares)       29,000        
Forfeiture of restricted stock awards (in shares)       (3,000)        
Issuance of common stock upon vesting of restricted stock units (in shares)       29,000        
Shares issued under employee stock purchase plan (in shares) 46,273     46,000        
Shares issued under employee stock purchase plan $ 3,063       3,063      
Issuance of stock related to acquisition (in shares)       50,000        
Issuance of stock related to acquisition 5,000       5,000      
Common stock redeemed for tax liability (in shares)       (11,000)        
Common stock redeemed for tax liability (1,117)       (1,117)      
Other comprehensive income gain (loss), net of tax 371         371    
Net income 283,230           283,230  
Ending balance (in shares) at Dec. 30, 2021     105,760,650 105,761,000        
Ending balance at Dec. 30, 2021 $ 1,323,199     $ 106 $ 450,332 $ 535 $ 872,226